Background. Coronary artery calcification scores (CACS) calculated by electron beam computed tomography (EBCT) have been correlated with atherosclerotic burden in the non-uraemic population. However, the validity of this test in chronic haemodialysis patients (HD) is currently uncertain. In the present cross-sectional study, associations between carotid atherosclerosis and coronary calcification in HD patients are investigated. Methods. We studied 79 chronic HD patients (39 male, 40 female; mean age, 45±12 years). The mean time on HD was 68±54 months (range, 6-187 months). In these patients, we measured serum calcium, phosphorus, total cholesterol, cholesterol subgroups and iPTH levels. EBCT, echocardiography, and high-resolution B-mode carotid Doppler ultrasonography were also performed. Results. Plaque-positive HD patients had significantly higher CACS than plaque-negative patients (851±199 vs 428±185, mean±SE, P ¼ 0.006). Coronary calcification scores were correlated with serum phosphorus (r ¼ 0.37; P ¼ 0.001). Only 8 of the 24 HD patients without coronary calcification had carotid plaques (33%), whereas 34 of the 53 patients with coronary calcification had carotid plaques (64%) (P ¼ 0.015). Carotid plaque scores were correlated with CACS (r ¼ 0.40; P ¼ 0.001). A stepwise linear regression (model r ¼ 0.72; P<0.001) revealed that CACS (logtransformed data of CACS) was associated with age (P<0.001), time on dialysis (P ¼ 0.004), serum phosphorus level (P ¼ 0.016) and carotid plaque scores (P ¼ 0.037).
Introduction
Despite advances in haemodialysis, cardiovascular mortality is high and remains the most important cause of death in ESRD patients [1] . In this patient group, accelerated atherosclerosis, left ventricular hypertrophy, hypertension and arrhythmias contribute to high cardiovascular mortality [2, 3] . Electron beam computed tomography (EBCT), a well-established method for detecting coronary artery calcification, has been proposed as a non-invasive method to predict coronary artery disease [4, 5] . In addition, coronary artery calcification scores (CACS), calculated using EBCT, have been found to be correlated with atherosclerotic burden in patients without chronic renal failure [6] . Furthermore, associations between coronary calcification and extracoronary atherosclerosis assessed by B-mode ultrasonography have been reported in nonuraemic population [7, 8] . In a recent study by Oh et al. [9] , both EBCT and carotid Doppler ultrasonography were used in patients with ESRD. Here, CACS was found to be associated with certain atherosclerotic risk factors, such as C-reactive protein. However, they did not find a correlation between intima media thickness and CACS. Therefore, the validity of CACS as measured by EBCT is currently undetermined in chronic haemodialysis (HD) patients. In these patients, increases in CACS have been reported [10] [11] [12] [13] . In patients with ESRD, impaired divalent ion metabolism increases the risk of calcification in peripheral vessels as well as in soft tissue and skin. Hyperphosphataemia, an increased CaÂP product, or both may lead to coronary calcification. In fact, coronary calcification in HD patients was correlated with serum phosphorus levels or with the CaÂP product in one study [10] , but not in another [11] . Because HD patients have other factors in addition to atherosclerosis that are involved in coronary calcification, the relationship between CACS and atherosclerosis is unclear in this group of patients. Carotid atherosclerosis measured by high resolution B-mode ultrasound is a valid non-invasive marker for systemic atherosclerosis that has been used for this purpose in patients with and without chronic renal failure [14, 15] . In the present cross-sectional study, we also used carotid atherosclerosis as a non-invasive surrogate marker of coronary atherosclerosis, and aimed to investigate the association of atherosclerosis with coronary calcification in HD patients.
Subjects and methods

Patients
For this cross-sectional study, we recruited 79 chronic HD patients (39 male, 40 female; mean age, 45±12 years). Included were patients >18 and <65 years in age, and who had been dialyzed for at least 6 months. Patient characteristics are shown in Table 1 . The mean time on CHD was 68±54 months (range, 6-187 months). At the time of the study, 69 patients were dialyzed three times a week and 10 patients were dialyzed twice a week. The duration of dialysis was 4 h per session with a blood flow rate of 250-300 ml/min and with a dialysate flow of 500 ml/min. All patients were dialyzed with standard bicarbonate containing dialysate bath (Na, 138 mmol/l; K, 1.25 mmol/l; HCO 3 , 33 mmol/l; Ca, 1.75 mmol/l; Mg, 0. 75 mmol/l). Etiologies of renal diseases were primary glomerular diseases (n ¼ 14), tubulointerstitial nephritis (n ¼ 14), diabetic nephropathy (n ¼ 5), hypertensive nephrosclerosis (n ¼ 3), other causes (n ¼ 17) and unknown etiology (n ¼ 26). Twenty-eight of the 79 patients (35%) were hypertensive. Antihypertensive medications included angiotensin converting enzyme inhibitors or angiotensin II receptor blockers (n ¼ 10), calcium channel blockers (n ¼13), alpha blockers (n ¼ 14), beta blockers (n ¼ 4) and alpha-methyl dopa (n ¼ 3). Ischaemic heart disease, evaluated from history, physical examination, ECG and echocardiographic investigations, was detected in 17 of the patients (22%). Fifty-eight of the patients (73%) were under calcium acetate treatment (Phosex tablet 250 mg, 750-2000 mg/day) as a phosphate binder. Forty-nine of the 79 patients (62%) were on oral or intravenous vitamin D treatment. Fifty-two of the patients (66%) were receiving erythropoietin treatment at the time of the study. All patients were examined using good medical and laboratory practice according to the recommendations set forth by the Declaration of Helsinki on Biomedical Research involving Human Subjects.
Methods
After 5 min of rest, blood pressure was measured manually using an Erka sphygmomanometer. Patients were considered hypertensive with predialytic systolic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg, or if they received antihypertensive drug treatment. In all patients, we measured blood urea nitrogen, serum creatinine, total protein, albumin, total cholesterol, HDL-cholesterol, triglyceride levels, complete blood counts, and electrolytes including calcium, phosphorus and magnesium. Serum cholesterol and triglyceride levels were analysed by standard enzymatic procedures. HDL-cholesterol levels were determined after precipitation of apoB-containing lipoproteins by phosphotungstic acid. LDL-cholesterol levels were calculated according to the Friedewald formula when triglyceride levels were lower than 400 mg/dl:
þ HDL-cholesterolÞ Serum intact PTH levels were measured by immunoradiometric assay using a commercially available kit (DSL-8000; Diagnostic Systems Laboratories, Inc., Webster, TX, USA). Blood samples for biochemical parameters and serum iPTH levels were drawn once just before haemodialysis during the post-absorptive state.
To detect mitral and aortic valve calcifications, echocardiographic examinations were done using a Vingmed System Five, Norway echocardiographic system equipped with 2.5 MHz transducers. M-Mode and 2D measurements were done in accordance with methods recommended by the American Society of Echocardiography [16, 17] .
B-mode high resolution carotid Doppler examination
Doppler ultrasonographic examinations were performed in 77 patients (98%) using a Vingmed System Five, Norway echocardiographic system equipped with 10 mHz linear transducers. A trained sonographer scanned the right and left common carotid arteries, the carotid bulbs, and the first 2 cm of the internal and external carotid arteries. For each location, the sonographer visualized the vessel in multiple planes and then focused on the interfaces required to measure intima-media thickness (IMT) as well as any areas of focal plaque. IMT measurements were performed at 20 mm from the bifurcation in the plaque-free area of carotis communis. It was measured three to four times in both sites and the mean of these measurements was recorded for analysis. Carotid plaque was defined as echogenic structures showing protrusion into the lumen with focal widening that was 50% greater than the IMT of adjacent sites. The degree of carotid artery stenosis was measured in four different locations (communis, bulbus, interna and externa) on both sites of the carotid arteries. Carotid plaque scores were calculated as the sum of degree of stenosis degrees in all locations. The intra-observer variability for IMT measurements was 4.8%, and the absolute difference between replicate IMT measurements was 0.03 mm.
All measurements were performed by a single investigator who was blinded to clinical details and laboratory results of the patients. These measurements were recorded on VHS videotape for subsequent off-line analysis.
Electron beam computed tomography examination
EBCT studies were performed with an Ultrafast C-150 scanner (GE-Imatron; CA, USA). A scan run consisted of acquisition of 40 contiguous transverse two-dimensional images of 3-mm-thick sections at the level above the coronary artery origins to the cardiac apex. Exposure duration was 0.1 s per tomographic level, and other parameters were 130 kVp, 630 mA. Images were acquired with ECG triggering at 71% of the R-R interval during diastole, and were obtained using a 26-cm 2 field of view and a 512Â512 reconstruction matrix. Contrast agents were not used. A calcification was defined as a minimum of two adjacent pixels (>0.52 mm 2 ) with a density over 130 Hounsfield units. The peak intensity (Hounsfield unit) and area (mm 2 ) of the individual calcifications were calculated. As described by Agatston et al. [18] , calcium scores were obtained by multiplying each area of interest by a factor indicating peak density within the individual area. Image quality and scoring accuracy was assessed by one radiologist (S. Tepe) who carefully made vessel-by-vessel and calcific focus-by-calcific focus inspections of each image. The radiologist was blinded to the clinical and laboratory results of the patients (Figure 1 ).
Statistical analysis
Statistical analysis was carried out using the Statistical Package for Social Sciences for Windows version 10.0 (SPSS Inc; Chicago, IL, USA). Numerical variables are presented as means±standard deviations or means±standard error when distributions were abnormal. Comparisons of two groups were made with unpaired Student's t-tests or Mann-Whitney U tests, and three groups with Kruskal Wallis-H analysis of variance. Chi-square tests with Yates correction and Fisher's exact tests were used for 2Â2 contingency tables when appropriate for non-numerical data. Correlations between numerical parameters were analysed with Spearman's rho correlation test. Because the CACS data had a highly skewed distribution and a high relative frequency of zero values, we performed logarithmic transformation on these values. To detect predictors of CACS [log(CACS þ 1)], we entered age, dialysis vintage, serum phosphorus levels and carotid plaque scores as independent variables in a stepwise linear regression analysis. P-values<0.05 were accepted as significant.
Results
Of the study population, 29 HD patients (37%) were smokers or ex-smokers. According to patient history, ECG, and echocardiographic examinations, 15 patients (19%) had ischaemic heart disease and 5 of them (6%) had history of myocardial infarction. Five HD patients (6%) had diabetes mellitus. Fifty-nine of the patients (75%) were oligoanuric (daily urine output <100 ml). Calcifications of mitral (14 patients, 18%) and aortic valves (14 patients, 18%) were detected using echocardiography, and four patients had both mitral and aortic valve calcifications.
On EBCT examination, 24 HD patients (30%) had no coronary artery calcification, whereas 55 patients (70%) had coronary calcifications of differing severities. Comparisons between HD patients having coronary calcification and those without are shown in Table 1 . Patients with coronary calcification had greater ages (49±11 vs 35±10 years, P<0.001) and body mass index (23±4 vs 20±3 kg/m 2 , P ¼ 0.007) than patients without calcification. There were no calcification differences for gender, smoking rate, or prevalence rates of hypertension and diabetes mellitus. Time on dialysis correlated with CACS in the study group (r ¼ 0.32, P ¼ 0.005). Serum phosphorus levels and the CaÂP product in patients with coronary calcification were higher than in patients without calcification, although these differences did not reach statistical significance. Coronary calcification scores were correlated with serum phosphorus levels (r ¼ 0.37, P ¼ 0.001) and the CaÂP product (r ¼ 0.39, P<0.001). After dividing patients into low iPTH (iPTH< 100 pg/ml; mean iPTH levels, 43±28 pg/ml, n ¼ 22) suggesting low bone turnover, and high iPTH (iPTH>400 pg/ml; mean iPTH levels, 974±454 pg/ml; n ¼ 25) groups, we found significantly increased CACS values in the high iPTH group (190±97 vs 1002± 299 pg/ml, mean±SE, P ¼ 0.02). Patients with ischaemic heart disease had significantly higher CACS scores than patients without ischaemic heart disease (1484± 441 vs 509±138, mean±SE, P ¼ 0.003). However, there was no CACS difference between smokers and non-smokers (919±315 vs 602±150, mean±SE, P>0.05).
Mitral and aortic valve calcifications were associated with coronary calcification. Thirteen of the 14 patients with mitral valve calcifications (93%) and 12 of 14 patients with aortic valve calcification (86%) had coronary calcification. Coronary calcification scores (mean±SE) were significantly higher in patients that had mitral (963±351 vs 665±165, P ¼ 0.05) or aortic valve leaflet calcifications (1566±519 vs 537±135, P ¼ 0.034) than in patients with normal mitral and aortic valves, despite a lack of difference in plaque scores [25±8 vs 34±7 for mitral valves and 27±12 vs 33±7 for aortic valves (mean±SE)].
When examining the four main segments of extracranial carotid arteries (common carotid, bifurcation, internal and external carotid) on both sides, we detected plaque in 42 of 77 HD patients (55%). Plaque-positive patients were significantly older (51±10 vs 37±11 years, P<0.001) than plaquenegative patients. IMT was higher in plaque-positive groups than plaque-negative patients (0.88±0.14 mm vs 0.74±0.14 mm, P<0.001). Coronary artery calcification scores in plaque positive patients were significantly higher than in plaque-negative patients (851±199 vs 428±185, mean±SE, P ¼ 0.006).
Eight of the 24 (33%) HD patients without coronary calcification had carotid plaque, whereas 34 of the 53 (64%) patients with coronary calcification had carotid plaque (P ¼ 0.015). The sensitivity of CACS for predicting atherosclerotic plaque in the carotid system was 81%; however, specificity of CACS was 46%. The ROC curve of CACS for predicting presence of carotid plaque is shown in Figure 2 . The cut-off point for CACS was 65 with 70% sensitivity and specificity.
In order to predict 50% stenosis (which is the generally accepted cut-off value of stenosis for intervention in coronary atherosclerosis) in any of the carotid artery segments, sensitivity and the negative predictive value of this test reached 89 and 96%, respectively. Moreover, patients with coronary calcification had significantly higher plaque scores than patients without coronary calcification (38.9±6.6 vs 17.1±11.4, P ¼ 0.004; Table 1 ). In addition, carotid plaque scores were correlated with CACS (r ¼ 0.40,
In a subgroup analysis of asymptomatic patients who did not have ischaemic heart disease, plaque-positive patients had higher CACS than plaque-negative patients (723±200 vs 116±49, mean±SE, P ¼ 0.002). There was also a significant correlation between CACS and plaque score in asymptomatic patients (r ¼ 0. 45, P<0.001).
When we divided patients into three groups according to carotid plaque score as Group I (carotid plaque score ¼ 0, n ¼ 35), Group II (carotid plaque score 40, n ¼ 22) and Group III (carotid plaque score >40, n ¼ 20), we found that prevalence of calcification increased in the groups having higher plaque scores (Figure 3) . Furthermore, CACS also increased in the groups with higher plaque scores (Figure 4) .
Stepwise linear regression analysis (model r ¼ 0.72, P<0.001) revealed that CACS was associated with age (P<0.001), time on dialysis (P ¼ 0.004), serum phosphorus levels (P ¼ 0.016) and carotid plaque score (P ¼ 0.037) in this patient population (Table 2) .
Discussion
Cardiovascular morbidity remains the leading cause of mortality in ESRD patients. Thus, ischaemic heart disease is more common in uraemic patients, who also show an accelerated atherosclerosis [1] . Coronary artery calcification measured by EBCT is a non-invasive test for predicting atherosclerotic burden in the nonuraemic population [4] [5] [6] . In patients without chronic renal failure, coronary artery calcification was associated with extracoronary atherosclerosis [7, 8] . However, this association is unclear in HD patients because of possible non-atherosclerotic factors causing coronary artery calcification, such as disordered mineral metabolism. In the present study, carotid plaque-positive patients had higher coronary calcification scores, and carotid plaque scores were correlated with CACS (r ¼ 0.40, P ¼ 0.001). Both CACS and the proportion of coronary calcification increased in parallel with severity of atherosclerosis (Figures 3 and  4) . HD patients with coronary calcification had a higher prevalence of carotid plaque and higher plaque scores than patients without coronary calcification. Linear regression analysis also revealed that carotid plaque scores were an independent predictor of coronary calcification scores together with age, time on dialysis, and serum phosphorus levels ( Table 2 ). These data strongly suggest that atherosclerosis is associated with development of coronary calcification. In previous work, Goodman et al. [10] reported high coronary calcification scores in young dialysis patients. However, the time on ESRD was quite long and did not exclude the presence of atherosclerosis in this group of patients. They also reported a lack of coronary calcification in patients younger than 20 years of age. Recently, Raggi et al. [12] reported that HD patients with ischaemic heart disease or angina had higher CACS, a finding that was replicated in the present study. Recently, Oh et al. [9] reported that CACS was associated with certain atherosclerotic risk factors such as C-reactive protein and hyperhomocysteinaemia. These findings support a role for atherosclerosis in the development of coronary calcification. In that study, IMT measured by carotid Doppler was used as a predictor of atherosclerosis. However, they could not find a significant correlation between IMT and CACS. Both HD (n ¼ 13) and renal transplant recipients (n ¼ 26) were enrolled in the study by Oh et al. [9] , but they did not investigate the relationship between plaque presence or severity of the atherosclerosis and CACS. In the present study, we found a more direct association between presence and/or severity of atherosclerosis and coronary calcification in HD patients. The difference in results is likely due to larger sample sizes and the homogenous nature of our study group. However, the accelerating effect of hyperphosphataemia or the high CaÂP product may overestimate the predicting value of coronary calcification for atherosclerosis in HD patients. Indeed, in our study, despite a reasonable sensitivity of CACS for predicting atherosclerotic plaque in the carotid system (81%), the specificity of this test was quite low (46%). The sensitivity of this test was higher (89%) for predicting more severe atherosclerotic plaque (>50% of stenosis). Uraemia related factors, such as disordered phosphorus metabolism, may exert additive effects on CACS, and therefore published guidelines for evaluating CACS in the non-uraemic population should be reconsidered for HD patients [19] .
Data from recent epidemiological studies show that hyperphosphataemia is an independent variable that is associated with increased cardiovascular mortality in HD patients [20, 21] . In our study, coronary calcification scores were associated with serum phosphorus levels and the CaÂP product, which are findings that are consistent with previous reports. This association indicates a possible role for hyperphosphataemia in cardiovascular mortality in HD patients. Recently, in a longitudinal study, Chertow et al. [13] reported that sevelamer treatment in HD patients led to a greater attenuation of coronary artery and aortic calcification than did calcium-based treatment. Both groups had comparable control of serum phosphorus, and these data suggested an independent role for calcium in vascular calcification. In our cross-sectional study, we did not find any differences in serum calcium levels. However, all of our patients had been dialysed by high calcium containing dialysate with calcium acetate as a phosphate binder, which may have led to a positive calcium balance and a high incidence of vascular calcifications. In addition, patients with high iPTH levels had greater CACS scores than patients with low iPTH levels, which suggests that coronary calcification may be associated more with high bone turnover metabolic bone disease than with low bone turnover. Further studies will be needed to specifically examine effects of calcium balance and bone turnover on coronary calcification in HD patients. Although EBCT provides a sensitive method for detecting coronary calcification, it cannot differentiate between intimal plaque calcification and media calcification, of which the latter occurs mainly in patients with uraemia. Therefore, this technique does not necessarily reflect the nature of coronary artery disease in these patients. In recent studies, coronary calcification in EBCT was found to be associated with cardiovascular mortality. In an autopsy study, it was found that atherosclerotic plaques in uraemic patients were more heavily calcified than in the normal population [22] . Although intravascular coronary ultrasonography would be helpful for comparing these groups, this method is invasive and expensive, and was not used in the present study.
Carotid plaque detection by Doppler ultrasound, a potential indicator of the coronary calcification burden, may be useful for screening for individual cardiovascular risk in patients with renal failure. However, results depend greatly on operator skill and the technical properties of the equipment. Furthermore, this is a semi-quantitative method for detection of vascular calcification. In contrast, EBCT is more expensive ("280 vs "80), but provides more quantitative and objective methods for measuring vascular calcification. Due to its easy accessibility and lower cost, the Doppler method is currently the most commonly used in routine clinical practice, whereas EBCT is still regarded as a research tool.
In conclusion, HD patients are characterized by atherosclerosis associated with coronary artery calcification, as well as hyperphosphataemia and/or hypercalcaemia. EBCT, which provides non-invasive testing with high sensitivity and negative predictive value for predicting atherosclerosis, could be recommended for screening of atherosclerosis, such as for pretransplant evaluation of ESRD patients. 
